30 Stocks Moving in Monday's Pre-Market Session

Author: Lisa Levin | February 10, 2020 08:30am

Gainers

vTv Therapeutics Inc. (NASDAQ:VTVT) rose 57.1% to $3.30 in pre-market trading after the company reported the results from part 2 of the Phase 2 Simplici-T1 study of TTP399 achieved the primary objective of a statistically significant reduction in HbA1c.
Mereo BioPharma Group plc (NASDAQ:MREO) shares rose 27.4% to $2.00 in pre-market trading. Mereo BioPharma reported a $5 million convertible equity financing with Novartis and disclosed a securities purchase deal with Aspire Capital Fund for up to $28 million.
Valeritas Holdings, Inc. (NASDAQ:VLRX) rose 24% to $0.79 in pre-market trading after the company announced an agreement for Zealand Pharma to acquire business and retain employees.
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares rose 22.7% to $12.56 in pre-market trading after the company reported the interim data from the Cohorts 1 and 2 of OPTIC Phase 1 trial of ADVM-022 intravitreal gene therapy showed robust efficacy with evidence of a dose-response. Cantor Fitzgerald upgraded Adverum Biotechnologies from Neutral to Overweight and raised the price target from $8 to $21.
Onconova Therapeutics, Inc. (NASDAQ:ONTX) rose 15.3% to $0.5650 in pre-market trading after climbing 12.28% on Friday.
Tesla, Inc. (NASDAQ:TSLA) rose 9% to $814.89 in pre-market trading following an article suggesting Google could acquire the company for $1500 per share which could raise Tesla's market cap to $1.5 trillion.
EQM Midstream Partners, LP (NYSE:EQM) rose 7.1% to $23.67 in pre-market trading.
L Brands, Inc. (NYSE:LB) shares rose 6% to $25.00 in pre-market trading following news the company is nearing a deal to sell its Victoria's Secret brand to private equity firm Sycamore Partners.
The Macerich Company (NYSE:MAC) rose 5.4% to $24.61 in pre-market trading after declining 6.26% on Friday.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares rose 5.1% to $3.35 in pre-market trading after the company received authorization from the U.S. FDA to begin Phase 1/2 clinical trial for INO-3107 to treat recurrent respiratory papillomatosis.
GameStop Corp. (NYSE:GME) shares rose 5% to $4.00 in pre-market trading after falling 8% on Friday.
Protalix BioTherapeutics, Inc. (NYSE:PLX) rose 4.9% to $3.65 in pre-market trading.
Martin Midstream Partners L.P. (NASDAQ:MMLP) rose 4.3% to $2.71 in pre-market trading.
Futu Holdings Limited (NASDAQ:FUTU) rose 3.9% to $11.80 in pre-market trading.
Trillium Therapeutics Inc. (NASDAQ:TRIL) rose 3.4% to $3.98 in pre-market trading.
Micro Focus International plc (NYSE:MFGP) rose 3.4% to $10.27 in pre-market trading.
Moderna, Inc. (NASDAQ:MRNA) rose 3.3% to $24.00 in pre-market trading after surging 16.90% on Friday.
Invitae Corporation (NYSE:NVTA) rose 3.3% to $23.75 in pre-market trading. Invitae is expected to release Q4 results on February 19.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Acasti Pharma Inc.(NASDAQ:ACST) fell 30% to $0.5299 in pre-market trading after the company issued an update on TRILOGY 1 and TRILOGY 2 Phase 3 trials of CaPre.
Biohaven Pharmaceutical Holding Company Ltd. (NASDAQ:BHVN) fell 16.1% to $43.00 in pre-market trading after the company reported that troriluzole study for generalized anxiety disorder missed primary endpoint.
Benitec Biopharma Limited (NASDAQ:BNTC) shares fell 10.5% to $6.66 in pre-market trading after jumping 40.64% on Friday.
Yield10 Bioscience, Inc. (NASDAQ:YTEN) fell 10.1% to $7.80 in pre-market trading after declining 17.33% on Friday.
Borr Drilling Limited (NYSE:BORR) fell 7.5% to $4.35 in pre-market trading.
My Size, Inc. (NASDAQ:MYSZ) fell 5.8% to $2.49 in pre-market trading after rising 9.58% on Friday.
Eli Lilly and Company (NYSE:LLY) fell 4.5% to $139.85 in pre-market trading after the company reported the results for Solanezumba from the Alzheimer's study did not meet its primary endpoint.
Viomi Technology Co., Ltd (NASDAQ:VIOT) fell 4.5% to $7.20 in pre-market trading.
Xunlei Limited (NASDAQ:XNET) fell 4.4% to $4.09 in the pre-market trading session.
Honda Motor Co., Ltd. (NYSE:HMC) fell 3.4% to $25.60 in pre-market trading. Honda Motor reported Q3 results on Friday.
Myriad Genetics, Inc. (NASDAQ:MYGN) fell 3.3% to $20.33 in pre-market trading. Myriad Genetics shares tumbled over 28% on Friday after the company reported worse-than-expected Q2 EPS and sales results.
Biogen Inc. (NASDAQ:BIIB) shares fell 3.3% to $327.69 in pre-market trading.